News & Press: Breaking News

ISCT Immediate Past President Massimo Dominici Presents at September 8th FDA Public Workshop

Thursday, September 8, 2016  
Share |

ISCT Immediate Past President Massimo Dominici Presents "Dissecting Unproven Cellular Therapies: The International Society for Cellular Therapy (ISCT) Position" at September 8th FDA Public Workshop: Scientific Evidence in Development of Human Cells, Tissues, and Cellular and Tissue-based Products Subject to Premarket Approval.


From Left to Right: Dan Weiss, ISCT Chief Scientific Officer, Massimo Dominici, ISCT Immediate Past President, and Jacques Galipeau, ISCT Mesenchymal Stem Cell Committee Chair From Left to Right: Dan Weiss, ISCT Chief Scientific Officer, Jacques Galipeau, ISCT Mesenchymal Stem Cell Committee Chair, Deborah Griffin, ISCT North America Legal and Regulatory Affairs Committee Chair, and Massimo Dominici, ISCT Immediate Past President
 
Massimo Dominici, ISCT Immediate Past President 

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.